N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: Behavioural and electrophysiological evidence

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 433-440

  D'Hooge, R ^b   Raes, A ^b   Lebrun, P ^b   Diltoer, M ^b   Van Bogaert, P P ^b   Manil, J ^b   Colin, F ^b   De Deyn, P P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

brain slice; cell culture; epilepsy; field potentials; Guanidino compounds; hippocampus; NMDA receptor; uraemia; whole cell recording

Indexed keywords

GUANIDINOSUCCINIC ACID; METHYLGUANIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; EVOKED RESPONSE; FEMALE; HIPPOCAMPUS; KIDNEY FAILURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; UREMIA;

EID: 0029952290     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)00011-1     Document Type: Article

References (45)

1. Alger B. E., Dhanjal S. S., Dingledine R., Garthwaite J., Henderson G., King G. L., Lipton P., North A., Schwartzkroin P. A., Sears T. A., Segal M., Wittingham T. S. and Williams J. (1984) Brain slice methods. In: Brain Slices (Dingledine R., Ed.), pp. 381-437. Plenum Press, New York.
2. Ascher P. and Nowak L. (1988) The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurons in culture. J. Physiol. 399: 247-266.
3. Collingridge G. L. and Lester R. A. J. (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40: 143-210.
4. Collingridge G. L., Kehl S. J. and McLennan H. (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334: 33-46.
5. Croucher M. J., Collins J. F. and Meldrum B. S. (1982) Anticonvulsant action of excitatory amino acid antagonists. Science 216: 899-901.
6. Curtis D. R., Duggan A. W., Felix D., Johnston A. R., Tebecis A. K. and Watkins J. C. (1972) Excitation of mammalian central neurons by acidic amino acids. Brain Res. 41: 283-301.
7. De Deyn P. P. and Macdonald R. L. (1990) Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann. Neurol. 28: 627-633.
8. De Deyn P. P., Marescau B., Cuykens J. J., Van Gorp L., Lowenthal A. and De Potter W. P. (1987) Guanidino compounds in serum and cerebrospinal fluid of non-dialysed patients with renal insufficiency. Clin. Chim. Acta 167: 81-88.
9. De Deyn P. P., Saxena V. K., Abts H., Borggreve F., D'Hooge R., Marescau B. and Crols R. (1992) Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol. Belg. 92: 191-209.
10. D'Hooge R., Pei Y. Q., Manil J. and De Deyn P. P. (1992a) The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice. Brain Res. 598: 316-320.
11. D'Hooge R., Pei Y. Q., Marescau B. and De Deyn P. P. (1992b) Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. J. neurol. Sci. 112: 96-105.
12. D'Hooge R., Pei Y. Q. and De Deyn P. P. (1993) N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice. Neurosci. Lett. 157: 123-126.
13. Fleck M. W., Henze D. A., Barrionuevo G. and Palmer A. M. (1993) Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus. J. Neurosci. 13: 3944-3955.
14. Hamill O. P., Marty A., Neher E., Sakmann B. and Sigworth F. J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100.
15. Keana J. F. W., McBurney R. N., Scherz M. W., Fischer J. B., Hamilton P. N., Smith S. M., Server A. C., Finkbeiner S., Stevens C. F., Jahr C. and Weber E. (1989) Synthesis and characterization of a series of diarylguanidines that are non-competitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties. Proc. natn. Acad. Sci. U.S.A. 86: 5631-5635.
16. Lapin I. P. (1982) Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology 21: 1227-1233.
17. Litchfield J. T. and Wilcoxon F. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96: 99-113.
18. Lodge D., Jones M. and Fletcher E. (1989) Non-competitive antagonists of N-methyl-D-aspartate. In: The NMDA Receptor (Watkins J.C. and Collingridge G.L., Eds), pp. 37-51. Oxford University Press, Oxford.
19. MacDonald J. F., Miljkovic Z. and Pennefather P. (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J. Neurophysiol. 58: 251-266.
20. MacDonald J. F. and Nowak L. M. (1990) Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmacol. Sci. 11: 167-172.
21. Matsumoto M., Kobayashi K., Kishikawa H. and Mori A. (1976) Convulsive activity of methylguanidine in cat and rabbits. IRCS Med. Sci. 4: 65.
22. Mayer M. L. and Westbrook G. L. (1984) Mixed-agonist action of excitatory amino acids on mouse spinal cord neurones under voltage clamp. J. Physiol. 354: 29-53.
23. Meldrum B. S. (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res. 12: 189-196.
24. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11: 379-387.
25. Minkoff L., Gaerther G., Darab M., Mercier C. and Levin M. L. (1972) Inhibition of brain sodium-potassium ATPase in uremic rats. J. Lab. clin. Med. 80: 71-78.
26. Monaghan D. T., Bridges R. J. and Cotman C. W. (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. A. Rev. Pharmacol. Toxicol. 29: 365-402.
27. Mori A. (1983) Guanidino compounds and neurological disorders. Neurosciences 9: 149-157.
28. Mori A. (1987) Biochemistry and neurotoxicology of guanidino compounds. History and recent advances. Pav. J. biol. Sci. 22: 85-94.
29. Morris R. G. M., Kandel E. R. and Squire L. R. (1988) The neuroscience of learning and memory: cells, neural circuits and behaviour. Trends Neurosci. 11: 125-127.
30. Neuman R. S., Ben-Ari Y., Gho M. and Cherubini E. (1988) Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the hippocampus in vitro. Neurosci. Lett. 92: 64-68.
31. Olverman H. J. and Watkins J. C. (1989) NMDA agonists and competitive antagonists. In: The NMDA Receptor (Watkins J. C. and Collingridge G. L., Eds), pp. 19-36. Oxford University Press, Oxford.
32. Osberg J. W., Meares G. J., McKee D. C. and Burnett G. B. (1982) Intellectual functioning in renal failure and chronic dialysis. J. Chron. Dis. 35: 445-457.
33. Patneau D. K. and Mayer M. L. (1990) Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10: 2385-2399.
34. Raskin N. H. (1989) Neurological aspects of renal failure. In: Neurology and General Medicine (M.J. Aminoff, Ed.), pp. 231-246. Churchill Livingstone, New York.
35. Reynolds I. J. (1990) Modulation of NMDA receptor responsiveness by neurotransmitters, drugs and chemical modification. Life Sci. 47: 1785-1792.
36. Reynolds I. J. and Rothermund K. (1992) Multiple modes of NMDA receptor regulation by guanidines. In: Guanidino Compounds in Biology and Medicine (De Deyn P. P., Marescau B., Stalon V. and Qureshi I. A., Eds), pp. 441-448. John Libbey, London.
37. Souheaver G. T., Ryan J. J. and Dewolfe A. S. (1982) Neuropsychological patterns in uremia. J. clin. Psychol. 38: 490-496.
38. Spencer P. S., Ludolph A. C. and Kisby G. E. (1993) Neurologic diseases associated with use of plant components with toxic potential. Env. Res. 62: 106-113.
39. Squire L. R. (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99: 195-231.
40. Stone T. W. and Connick J. H. (1985) Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 15: 597-617.
41. Turski L. and Turski W. A. (1993) Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia 49: 1064-1072.
42. Watkins J. C. and Collingridge G. L., Eds (1989) The NMDA Receptor. Oxford University Press, Oxford.
43. 50) and instructions in their use. Biometrics 8: 249-263.
44. Wong E. H. F. and Kemp J. A. (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. An. Rev. Pharmacol. Toxicol. 31: 401-425.
45. Yokozawa T., Mo Z. L. and Oura H. (1989) Comparison of toxic effects of methylguanidine, guanidinosuccinic acid and creatinine in rats with adenine-induced chronic renal failure. Nephron 51: 388-392.